{"id":"W4389451159","doi":"10.1212/wnl.80.7_supplement.in10-2.002","title":"Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio (IN10-2.002)","year":2013,"lang":"en","type":"article","venue":"Neurology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Clinical endpoint; Placebo; Internal medicine; Progression-free survival; Interim analysis; Phases of clinical research; Surgery; Oncology; Radiation therapy; Clinical trial; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002441417,0.002397473,0.002732748,0.0006082325,0.0004604288,0.00126201,0.001698035,0.001715946,0.003436894],"category_scores_gemma":[0.001262903,0.0008880287,0.001698007,0.000624254,0.001234614,0.0011115,0.0005138906,0.004957296,0.001176211],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002038339,"about_ca_system_score_gemma":0.002902894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003371937,"about_ca_topic_score_gemma":0.01029655,"domain_scores_codex":[0.9992611,0.0003669226,0.00003720142,0.0001246186,0.00006385841,0.0001463499],"domain_scores_gemma":[0.9987367,0.0001710782,0.0002741944,0.00008524775,0.00007097667,0.0006618843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9063956,0.03513895,0.002892136,0.0004084503,0.00203574,0.0001806244,0.0001169587,0.001320734,0.0130065,0.0001698241,0.003303996,0.03503041],"study_design_scores_gemma":[0.7323407,0.2555056,0.006554946,0.00003078084,0.0008463281,0.0001897935,0.00004202992,0.0008832791,0.001882453,0.0001585557,0.001535074,0.00003039741],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906804,0.002274634,0.0004855625,0.0007661705,0.0003695665,0.001813423,0.001535655,0.0001343474,0.001940195],"genre_scores_gemma":[0.9850805,0.002020079,0.001996318,0.001182048,0.0003756161,0.002026257,0.004235515,0.00006794459,0.003015633],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003436894,"threshold_uncertainty_score":0.01478928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02247598227843454,"score_gpt":0.3040535197584361,"score_spread":0.2815775374800015,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}